The number of protein based pharmaceuticals reaching the marketplace has exponentially increased over the past few years. As the global demand for innovative protein therapeutics is growing each year, a large number of investors are pouring money in the market. Moreover, new developments in manufacturing & production technology have led to significant advancements in protein manufacturing and production. The global protein therapeutics market registered a robust growth rate of over 14% in 2008.
According to our new research report “Global Protein Therapeutics Market Analysis”, the global protein therapeutics market is expected to grow at a CAGR of around 12% during 2010-2012. At present, the market is characterized by high cost treatments therapy and healthcare insurance which in turn helping the companies to generate more revenue.
Our report has found that the market is presently dominated by Monoclonal Antibodies. With double-digit growth projected for future, the segment is expected to bolster its dominant position. Insulin, Interferon Beta, G-CSF and coagulation factors are also exhibiting healthy growth rates. One of the biggest opportunity areas in the protein therapeutics market is biogenerics which are expected to create a multi-billion dollar market in future. Moreover, pharmaceutical contract research and manufacturing market is expected to grow at an unmatched rate on account of high cost factor in the market.
This report provides extensive information and rational analysis of the global protein therapeutics market. It includes detailed study of factors fueling growth in the protein therapeutics market to help clients gain deeper insight of the current and future trends in the global protein therapeutics market. The report also provides segment-wise market trends prevailing at regional level to provide an overview of developments taking place in these segments across the world.
